CELLeBRAIN
PrivateLast Round
Series B
Dec 1, 2024
Est. Valuation
$21.16M
Total Funding Raised
$8.83M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
CELLeBRAIN is a biotechnology company that develops stem cell-based gene therapies for the treatment of cancers and chronic degenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CELLeBRAIN Comparables
Compare CELLeBRAIN with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iXgene Inc. | 78% | |
| SCM Lifescience | 63% | |
| ENCell Co., Ltd. | 61% |
CELLeBRAIN Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 1, 2024 | ||||
| Series A | Dec 1, 2021 | ||||
| Corporate Funding | Feb 1, 2021 | ||||
| Pre Seed | Oct 1, 2019 |
CELLeBRAIN Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Laguna Investment | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 25, 2026
Monthly visitors increased 31% MoM.
- Apr 8, 2026
Monthly visitors grew 232% MoM, reaching 2.5K.
CELLeBRAIN Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CELLeBRAIN's valuation, stock price, and market status.
Is CELLeBRAIN a public or private company?
CELLeBRAIN is a private company.
What is the current stock price of CELLeBRAIN?
CELLeBRAIN is a private company with no public stock price. Caplight tracks CELLeBRAIN's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is CELLeBRAIN worth (valuation)?
CELLeBRAIN's valuation is estimated at $21.2M based on funding round data.
Can I buy CELLeBRAIN stock?
CELLeBRAIN shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CELLeBRAIN's last funding round?
CELLeBRAIN's most recent funding round was Series B on December 1, 2024.
Who are the main investors in CELLeBRAIN?
Key investors in CELLeBRAIN include Laguna Investment.
Will CELLeBRAIN IPO soon?
No public IPO plans have been announced for CELLeBRAIN.
How can I track CELLeBRAIN secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CELLeBRAIN's secondary market activity and sign up for updates.